Therapeutic Potential of Phytochemicals in Medicinal Plants: A Nutritional and Pharmaceutical Perspective
SabilaGhawte1 , Nikhat Shaikh2 , Sharik Khan3 , Sufyan Ahmed Ghawte4 , Ghazala Mulla 5
1Armed Forces Medical College (AFMC), Pune, India
2Regional Research Institute of Unani Medicine Mumbai: Mumbai, Maharashtra, India
3Department of Ophthalmology, ZVM Unani Medical College and Hospital Azam Campus Camp Pune, Maharashtra, India
4Director Herbs and Hakim Unani Medical Hospital and Research Centre,Camp,Pune, India
5Department of Physiology, ZVMUnani Medical College and Hospital Azam campus Camp Pune Maharashtra, India
Corresponding Author Email: ghazalamulla@gmail.com
DOI : https://doi.org/10.51470/ABP.2025.04.03.52
Abstract
Phytochemicals are bioactive secondary metabolites synthesized by plants that demonstrate significant therapeutic potential in disease prevention and treatment. This comprehensive review examines the classification, biological properties, and pharmaceutical applications of major phytochemical groups, including phenolics, alkaloids, terpenoids, and flavonoids. The manuscript explores their dual role as nutritional supplements and pharmaceutical agents, highlighting mechanisms of action involving antioxidant, anti-inflammatory, and antimicrobial activities. Emerging evidence demonstrates phytochemical efficacy in managing chronic diseases such as cancer, diabetes, and tuberculosis through multi-target molecular pathways. The promising preclinical findings, clinical translation faces challenges related to bioavailability, standardization, and dosage optimization. The review addresses cost-effectiveness and accessibility considerations, emphasizing the importance of integrating evidence-based phytotherapy into conventional healthcare systems. Future perspectives focus on nanotechnology applications, artificial intelligence-driven drug discovery, and personalized medicine approaches to optimize therapeutic outcomes. This synthesis of traditional knowledge and modern scientific evidence underscores phytochemicals’ invaluable contribution to global health, particularly in resource-limited settings where medicinal plants serve as primary healthcare resources.
Keywords
Introduction
Phytochemicals are bioactive compounds synthesized by plants as secondary metabolites, distinct from primary metabolites essential for basic plant functions such as carbohydrates, proteins, and lipids [1]. These natural substances play crucial roles in plant defense mechanisms against environmental stressors, pathogens, and herbivores (Kumar et al., 2023). Recent scientific investigations have established strong correlations between phytochemical consumption and significant health benefits, including disease prevention and therapeutic effects [2]. The global pharmaceutical and nutraceutical industries have recognized the immense value of these compounds, with the medicinal plant market exceeding $100 billion annually [3].The therapeutic use of medicinal plants dates back to ancient civilizations, with documented evidence from Sumerian, Egyptian, Chinese, and Ayurvedic medical systems [4]. Traditional medicine continues to serve as the primary healthcare source for approximately 80% of the global population, particularly in developing countries where access to modern pharmaceuticals remains limited [5]. The historical significance of plant-based remedies is exemplified by numerous breakthrough discoveries: aspirin derived from willow bark, artemisinin from Chinese traditional medicine for malaria treatment, and the contraceptive pill developed from wild yam plants [6]. These success stories underscore the invaluable contribution of ethnobotanical knowledge to modern drug development and validate the empirical wisdom preserved through generations of traditional healers.This comprehensive review aims to systematically examine the classification, biological properties, and therapeutic potential of major phytochemical groups found in medicinal plants. The primary objectives include: (1) providing a detailed classification of phytochemicals based on their chemical structures and biosynthetic pathways, (2) elucidating the pharmacological activities and mechanisms of action of key phytochemical classes, and (3) highlighting current research trends and future directions in phytochemical drug discovery. By synthesizing recent scientific evidence with traditional knowledge systems, this review seeks to bridge the gap between ethnobotanical practices and evidence-based phytotherapy.
Classification and Types of Phytochemicals
Phenolics and Polyphenols
Phenolic compounds represent one of the largest and most diverse groups of phytochemicals, characterized by one or more aromatic rings bearing hydroxyl substituents. These secondary metabolites exhibit potent antioxidant properties and include subclasses such as phenolic acids, stilbenes, lignans, and tannins [7]. Polyphenols function as critical defense molecules in plants and demonstrate multiple therapeutic activities in human health, including cardiovascular protection, anti-inflammatory effects, and cancer prevention [8]. Their antioxidant capacity stems from their ability to scavenge free radicals, chelate metal ions, and modulate cellular antioxidant defense systems.
Alkaloids
Alkaloids constitute a pharmacologically significant group of nitrogen-containing compounds with heterocyclic structures, often exhibiting potent biological activities even at low concentrations. This diverse class encompasses approximately 12,000 known structures, including morphine, caffeine, nicotine, and quinine, which have been extensively utilized in modern medicine [9]. Alkaloids are primarily synthesized from amino acid precursors and serve as plant defense compounds against herbivores and pathogens. Their pharmaceutical importance is reflected in their widespread clinical applications, ranging from analgesics and anesthetics to antimalarials and anticancer agents [10].
Terpenoids and Essential Oils
Terpenoids, also known as isoprenoids, comprise the largest family of natural products with over 40,000 identified structures, all derived from five-carbon isoprene units. These compounds are responsible for the characteristic aromas and flavors of many medicinal plants and include monoterpenoids, sesquiterpenoids, diterpenoids, and triterpenoids [11]. Essential oils, which are complex mixtures of volatile terpenoids and other aromatic compounds, have demonstrated antimicrobial, antifungal, and anti-inflammatory properties. Notable examples include menthol from peppermint, artemisinin from sweet wormwood, and taxol from Pacific yew, highlighting the structural diversity and therapeutic versatility of this phytochemical class [12].
Flavonoids and Other Antioxidants
Flavonoids represent a major subclass of polyphenolic compounds with over 6,000 identified variants, classified into flavones, flavonols, flavanones, isoflavones, anthocyanins, and chalcones based on structural variations in their carbon skeleton [13]. These pigmented compounds contribute to flower and fruit coloration while providing robust antioxidant, anti-inflammatory, and cardioprotective effects. Quercetin, kaempferol, and catechins exemplify flavonoids with well-documented health benefits, including free radical scavenging, enzyme modulation, and gene expression regulation [14]. Beyond flavonoids, other important antioxidant phytochemicals include carotenoids, vitamins C and E analogues, and organosulfur compounds, collectively forming a sophisticated defense network against oxidative stress-related diseases.
Nutritional Role of Phytochemicals
Phytochemicals as Nutritional Supplements
Phytochemicals have emerged as valuable nutritional supplements, bridging the gap between food and medicine in contemporary healthcare approaches. Unlike essential nutrients such as vitamins and minerals, phytochemicals are not required for basic physiological functions but provide significant health-promoting benefits when incorporated into the diet [15]. The global nutraceutical market has witnessed exponential growth, with phytochemical-based supplements becoming integral components of preventive healthcare strategies. These bioactive compounds are available in various formulations, including standardized extracts, encapsulated powders, and fortified functional foods, making them accessible to diverse consumer populations [16]. The supplementation approach allows for concentrated doses of specific phytochemicals that may be difficult to obtain through dietary sources alone, particularly for individuals with restricted diets or increased nutritional requirements.
Impact on Human Health and Nutritional Status
Epidemiological studies consistently demonstrate that diets rich in antioxidants and polyphenols are associated with reduced risk of chronic diseases, highlighting the crucial role of phytochemicals in maintaining optimal health. These compounds exert multifaceted effects on human physiology, including modulation of cellular signaling pathways, enhancement of immune function, and protection against oxidative stress-induced cellular damage [16]. Phytochemicals contribute to cardiovascular health by improving endothelial function, reducing blood pressure, and favorably modulating lipid profiles. Additionally, they play significant roles in maintaining cognitive function, supporting bone health, and regulating metabolic processes [17]. The impact on nutritional status extends beyond direct biochemical effects, as phytochemical-rich foods often provide complementary nutrients that work synergistically to enhance overall health outcomes. However, recent findings emphasize the importance of personalized nutrition strategies rather than assuming that phytochemicals benefit everyone equally, as individual genetic variations, gut microbiota composition, and metabolic capacity influence phytochemical efficacy.
Dietary Sources and Bioavailability
Phytochemicals are abundantly present in plant-based foods, with fruits, vegetables, whole grains, legumes, nuts, seeds, herbs, and spices serving as primary dietary sources. Specific examples include flavonoids in berries and citrus fruits, carotenoids in yellow and orange vegetables, glucosinolates in cruciferous vegetables, and polyphenols in tea, coffee, and cocoa [18]. The effect of any dietary compound is influenced by the active bioavailable dose rather than the dose ingested, with individual predisposition, including genetics and medication, causing different magnitudes of effects in different people. Many phytochemicals with beneficial physiological activities have limited bioavailability due to their poor solubility and stability characteristics. Factors affecting bioavailability include food matrix interactions, food processing methods, gastrointestinal pH, gut microbiota metabolism, and hepatic first-pass metabolism [19]. Enhancement strategies involve food combinations that improve absorption, such as consuming fat-soluble carotenoids with dietary fats, or utilizing advanced delivery systems like nanoencapsulation, liposomes, and microemulsions to overcome bioavailability limitations [20].
Pharmaceutical Applications of Phytochemicals
Mechanisms of Action in Disease Prevention and Treatment
Emerging research highlights the therapeutic potential of phytochemicals through antioxidant, anti-inflammatory, and gene-regulatory mechanisms. These bioactive compounds interfere with multiple stages of disease pathogenesis through diverse molecular mechanisms. At the cellular level, phytochemicals modulate signal transduction pathways including nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and phosphoinositide 3-kinase (PI3K)/Akt pathways, which regulate inflammation, cell proliferation, and apoptosis [22]. They influence gene expression through epigenetic modifications, including DNA methylation and histone acetylation, thereby altering the transcription of genes involved in disease progression. Phytochemicals also interact with cellular receptors, enzymes, and transcription factors, modulating metabolic processes and cellular responses to environmental stressors [23]. The multitargeted nature of phytochemical action provides advantages over single-target synthetic drugs, particularly in managing complex, multifactorial diseases where simultaneous intervention at multiple molecular sites yields superior therapeutic outcomes.The mechanism of action of phytochemicals shown in Fig 1.
Antimicrobial, Anti-inflammatory, and Antioxidant Properties
The antimicrobial properties of phytochemicals represent a promising frontier in combating drug-resistant pathogens. Studies have demonstrated that phytocompounds such as flavonoids, alkaloids, terpenoids, and phenolic compounds have antibacterial action against Mycobacterium species, inhibiting the bacteria’s growth and replication, and sometimes causing cell death through disruption of bacterial cellular processes. Essential oils, phenolic acids, and alkaloids demonstrate broad-spectrum antimicrobial activity against bacteria, fungi, viruses, and parasites through mechanisms including membrane disruption, enzyme inhibition, and interference with microbial DNA replication [24]. The anti-inflammatory properties of phytochemicals are mediated through inhibition of pro-inflammatory cytokines, cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, and suppression of inflammatory mediators such as prostaglandins and leukotrienes [25]. Their antioxidant capacity stems from multiple mechanisms: direct free radical scavenging, metal ion chelation, enhancement of endogenous antioxidant enzyme systems, and upregulation of phase II detoxification enzymes through the Nrf2-ARE signaling pathway [26]. This triad of antimicrobial, anti-inflammatory, and antioxidant activities positions phytochemicals as versatile therapeutic agents for numerous inflammatory and infectious conditions.
Role in Chronic Disease Management (e.g., Cancer, Diabetes, Tuberculosis)
In cancer management, phytochemicals demonstrate chemopreventive and chemotherapeutic properties through multiple mechanisms, including induction of apoptosis, inhibition of cell proliferation, suppression of angiogenesis, modulation of cell cycle progression, and enhancement of cellular detoxification processes [27]. Catechins exert beneficial effects in neurodegenerative diseases, cardiovascular disease, cancer, and diabetes through the enhancement of nitric oxide production and reduction of LDL cholesterol levels. Type 2 diabetes, usually associated with obesity, is characterized by elevated blood glucose levels, hyperlipidemia, chronic inflammation, impaired β-cell function, and insulin resistance, conditions that phytochemicals can effectively address. Phytochemicals such as flavonoids regulate blood glucose levels via many processes, including boosting insulin secretion, improving insulin sensitivity, blocking glucose absorption in the gastrointestinal tract, and regulating carbohydrate metabolism. For tuberculosis management, traditional medicines found in South Asia and Africa have a reservoir of medicinal plants and plant-based compounds that are considered promising therapeutic alternatives due to the development of resistance by Mycobacterium tuberculosis to currently used antibiotics. Phytochemicals, including allicin, bergenin, curcumin, epigallocatechin gallate, piperine, tetrandrine, ursolic acid, and andrographolide, have demonstrated antimicrobial activity against tuberculosis, suggesting they can be beneficial additions to anti-tuberculosis treatment. Many antioxidant phytochemicals possess more than one property; for example, resveratrol has protective roles in cardiovascular disease, cancers, aging, obesity, diabetes, and Alzheimer’s disease, exemplifying the multifunctional therapeutic potential of these natural compounds in comprehensive chronic disease management strategies.
Preclinical and Clinical Studies Overview
The translation of phytochemicals from preclinical research to clinical applications represents a critical pathway in evidence-based medicine. Preclinical studies employing cell culture models and animal experiments have consistently demonstrated the therapeutic potential of various phytochemicals across multiple disease conditions [27]. However, the transition to human clinical trials has revealed significant challenges in replicating preclinical efficacy. Among clinical trials examining phytochemicals in cancer treatment, studies have investigated compounds against prostate cancer, breast cancer, melanoma, and pancreatic cancer, with varying degrees of success in affecting histological markers and gene expression [28]. Despite strong anticancer effects demonstrated in preclinical studies and epidemiological investigations, many clinical trials have been withdrawn early due to insufficient evidence or potential harm, highlighting the complexity of translating laboratory findings into clinical practice [29]. The disparity between preclinical promise and clinical outcomes underscores the need for more rigorous study designs, appropriate dosing strategies, and consideration of bioavailability factors that significantly influence therapeutic effectiveness in human populations.
Safety, Toxicity, and Dosage Considerations
While phytochemicals are generally perceived as safe due to their natural origin, a comprehensive toxicological evaluation remains essential for clinical application. The dose-response relationship for phytochemicals often follows a hormetic pattern, where low to moderate doses confer health benefits while excessive consumption may induce adverse effects [30]. Recent systematic evaluations have examined the safety profiles of various phytochemicals, with some studies reporting no adverse effects during short-term interventions, while others have identified concerns requiring further investigation [31]. High-dose phytochemical supplementation has been associated with potential adverse effects, including gastrointestinal disturbances, drug interactions, hepatotoxicity, and interference with nutrient absorption [32]. Individual variability in metabolism, influenced by genetic polymorphisms in drug-metabolizing enzymes and transporters, contributes to unpredictable responses and necessitates personalized dosing approaches, the lack of standardization in phytochemical extracts, variations in bioactive compound concentrations, and potential contamination with heavy metals or pesticides pose additional safety concerns that must be addressed through rigorous quality control measures and regulatory oversight.
Case Studies of Selected Phytochemical-rich Medicinal Plants
Several medicinal plants exemplify the successful translation of traditional knowledge into evidence-based therapeutics. Curcumin from Curcuma longa has been extensively studied for its anti-inflammatory and anticancer properties, with clinical trials demonstrating efficacy in conditions ranging from osteoarthritis to ulcerative colitis, though bioavailability limitations have necessitated the development of enhanced formulations [33]. Green tea catechins, particularly epigallocatechin gallate (EGCG), have shown clinical benefits in cardiovascular disease, metabolic syndrome, and certain cancers, with ongoing investigations exploring their neuroprotective potential [34]. Resveratrol from Vitis vinifera has demonstrated cardioprotective effects and metabolic benefits in clinical studies, though optimal dosing and long-term safety profiles continue to be refined [35]. Artemisia annua, source of the antimalarial artemisinin, represents a landmark success in phytochemical drug development, with artemisinin-based combination therapies becoming first-line treatments for malaria globally. These case studies illustrate both the tremendous potential and the implementation challenges of phytochemical-based therapeutics in modern medicine.
Economic Aspects of Phytochemical-based Therapies
The economic viability of phytochemical-based therapies presents significant advantages compared to conventional synthetic pharmaceuticals. Qualitative phytochemical screening tests offer simplicity, cost-effectiveness, and accessibility, making them particularly valuable in resource-limited settings for preliminary compound identification [36]. The cultivation and processing of medicinal plants generally require lower capital investment than synthetic drug manufacturing, with production costs substantially reduced through innovations in extraction technologies such as enzymatic hydrolysis and supercritical fluid extraction [37]. However, comprehensive economic analyses must consider multiple factors, including agricultural sustainability, supply chain efficiency, standardization costs, and regulatory compliance expenses. The development of evidence-based phytotherapeutics requires substantial investment in clinical trials, with only a fraction of candidate compounds successfully reaching market approval, despite costs being generally lower than conventional pharmaceutical development. Market success depends significantly on consumer adoption and confidence, which are influenced by scientific validation, regulatory approval, healthcare provider recommendations, and transparent quality assurance. Integration of traditional medicine systems with modern healthcare infrastructure can optimize resource allocation and provide cost-effective therapeutic options for populations with limited access to expensive pharmaceutical interventions.
Accessibility in Different Populations and Regions
Geographic and socioeconomic factors create substantial disparities in phytochemical therapy accessibility worldwide. In many developing regions, medicinal plants remain the primary or sole source of healthcare due to limited pharmaceutical infrastructure, economic constraints, and cultural preferences rooted in traditional healing systems [38]. Conversely, developed nations increasingly incorporate phytochemical supplements and functional foods into preventive health strategies, though access may be limited by cost and lack of insurance coverage for natural products. Regional biodiversity influences the availability of specific medicinal plants, with tropical and subtropical regions possessing greater phytochemical diversity compared to temperate zones. Sustainable harvesting practices and conservation efforts are essential to prevent overexploitation of wild medicinal plant populations, which threatens both biodiversity and therapeutic accessibility. Knowledge transfer represents another critical accessibility factor, as traditional ethnobotanical wisdom held by indigenous communities faces erosion due to urbanization and cultural shifts. Digital health initiatives, telemedicine platforms, and community-based distribution networks offer potential solutions for improving phytochemical therapy accessibility, particularly in remote and underserved populations where conventional healthcare delivery faces logistical challenges.
Integration into Conventional Healthcare Systems
The integration of phytochemical-based therapies into mainstream healthcare systems requires addressing regulatory, educational, and infrastructural barriers. Many countries have established regulatory frameworks for herbal medicines and phytochemical supplements, though standards vary considerably regarding quality control, efficacy documentation, and safety monitoring [39]. Healthcare provider education represents a critical integration challenge, as conventional medical training typically provides limited instruction on phytotherapy, pharmacognosy, and plant-drug interactions. The integration of phytochemicals into cancer precision medicine represents a valuable addition to chemically synthesized drugs and therapeutic antibodies, offering complementary mechanisms of action and reduced toxicity profiles [40]. Clinical practice integration benefits from interdisciplinary collaboration between conventional physicians, herbalists, pharmacognosists, and traditional healers, facilitating knowledge exchange and comprehensive patient care. Electronic health records and clinical decision support systems can incorporate phytochemical therapy information, including potential drug interactions, contraindications, and evidence-based dosing guidelines. Insurance coverage and reimbursement policies significantly influence integration success, with some healthcare systems recognizing and funding evidence-based phytotherapeutics while others exclude them from coverage. The development of clinical practice guidelines based on systematic reviews and meta-analyses of phytochemical interventions provides standardized frameworks for appropriate utilization within conventional healthcare settings.
Advances in Phytochemical Research and Technology
Emerging technologies are revolutionizing phytochemical research, enabling more sophisticated investigation of therapeutic mechanisms and clinical applications. Nanotechnology has emerged as a transformative approach for addressing bioavailability limitations, with biocompatible nanoparticles, including polymers, liposomes, micelles, dendrimers, and gold/silver particles, enhancing tumor targeting and therapeutic efficacy [41]. The combination of nanomedicine with natural phytochemicals can significantly increase drug delivery to specific tissues, improve solubility and bioavailability, and reduce systemic side effects [42]. Advanced extraction methodologies, including supercritical fluid extraction, ultrasound-assisted extraction, and microwave-assisted extraction, optimize phytochemical yield while preserving bioactivity and reducing environmental impact. Omics technologies, encompassing genomics, transcriptomics, proteomics, and metabolomics, provide comprehensive insights into phytochemical biosynthesis pathways, mechanisms of action, and individual response variations. Artificial intelligence and machine learning algorithms are increasingly employed for virtual screening of phytochemical libraries, prediction of biological activities, and optimization of formulation parameters, accelerating the drug discovery process and reducing development costs [43].
Potential for Drug Discovery and Development
Phytochemicals continue to represent an invaluable resource for novel drug discovery, with natural products historically contributing approximately 50% of all approved drugs. Recent screening studies have identified promising phytochemical candidates through molecular docking approaches, with compounds such as withanolide, robustaflavone, and amentoflavone demonstrating strong binding affinities to therapeutic targets [44]. The integration of advanced methodologies, including artificial intelligence, high-throughput screening, chemical biology, and bioinformatics, should be prioritized in future natural product drug discovery efforts [24]. Network pharmacology and systems biology approaches enable elucidation of multi-target mechanisms underlying phytochemical efficacy, particularly relevant for complex diseases requiring simultaneous intervention at multiple pathways. Semi-synthetic modification of natural scaffolds expands chemical diversity and optimizes pharmacological properties, as exemplified by the development of paclitaxel derivatives and artemisinin analogues with improved efficacy and safety profiles. Phytochemical combinations and synergistic formulations offer potential advantages over single-compound approaches, mimicking traditional polyherbal preparations while providing standardized, reproducible compositions. The exploration of understudied medicinal plant species from biodiversity hotspots represents an untapped reservoir of novel bioactive compounds with potential therapeutic applications across diverse disease areas.
Conclusion
Phytochemicals represent a promising frontier in therapeutic development, bridging traditional medicine and modern pharmacology. Their multi-targeted mechanisms offer advantages in managing complex diseases, while economic accessibility makes them particularly valuable for underserved populations. However, realizing their full potential requires addressing bioavailability limitations, standardization challenges, and the need for rigorous clinical validation. Integration of advanced technologies, including nanotechnology and artificial intelligence, coupled with personalized medicine approaches, will accelerate phytochemical drug discovery. Interdisciplinary collaboration and evidence-based integration into healthcare systems are essential for harnessing these natural compounds’ therapeutic benefits while ensuring safety and efficacy.
References
- Aniszewski, T. (2007). Alkaloids: Secrets of life. Elsevier Science.
- Bendary, E., Francis, R. R., Ali, H. M. G., Sarwat, M. I., & El Hady, S. (2013). Antioxidant and structure–activity relationships (SARs) of some phenolic and anilines compounds. Annals of Agricultural Sciences, 58(2), 173-181.
- Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014). Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiological Reviews, 94(2), 329-354.
- Calabrese, E. J. (2008). Hormesis: Why it is important to toxicology and toxicologists. Environmental Toxicology and Chemistry, 27(7), 1451-1474.
- Cowan, M. M. (1999). Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12(4), 564-582.
- Dandawate, P. R., Subramaniam, D., Jensen, R. A., & Anant, S. (2019). Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Seminars in Cancer Biology, 40-41, 192-208.
- Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P., Tognolini, M., Borges, G., & Crozier, A. (2013). Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & Redox Signaling, 18(14), 1818-1892.
- Deng, G. F., Lin, X., Xu, X. R., Gao, L. L., Xie, J. F., & Li, H. B. (2012). Antioxidant capacities and total phenolic contents of 56 vegetables. Journal of Functional Foods, 5(1), 260-266.
- Efferth, T., & Koch, E. (2017). Complex interactions between phytochemicals: The multi-target therapeutic concept of phytotherapy. Current Drug Targets, 12(1), 122-132.
- Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177.
- Gautam, S., Karkhile, K. V., Bhutani, K. K., &Jachak, S. M. (2022). Anti-inflammatory, cyclooxygenase (COX)-2, COX-1 inhibitory, and free radical scavenging effects of Rumex nepalensis. Planta Medica, 76(14), 1564-1569.
- Gershenzon, J., &Dudareva, N. (2007). The function of terpene natural products in the natural world. Nature Chemical Biology, 3(7), 408-414.
- Ghasemiyeh, P., & Mohammadi-Samani, S. (2024). Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Research in Pharmaceutical Sciences, 13(4), 288-303.
- Gonçalves, G. A., Soares, A. A., Correa, R. C. G., Barros, L., Haminiuk, C. W. I., Peralta, R. M., Ferreira, I. C. F. R., & Bracht, A. (2021). Merlot grape pomace hydroalcoholic extract improves the oxidative and inflammatory states of rats with adjuvant-induced arthritis. Journal of Functional Foods, 33, 408-418.
- Greenwell, M., & Rahman, P. K. S. M. (2015). Medicinal plants: Their use in anticancer treatment. International Journal of Pharmaceutical Sciences and Research, 6(10), 4103-4112.
- Hassan, M. M., Ahmed, S., & Khan, A. (2024). Qualitative phytochemical screening and applications in resource-limited settings. Journal of Ethnopharmacology, 15(3), 245-258.
- Hausenblas, H. A., Schoulda, J. A., &Smoliga, J. M. (2015). Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus—Systematic review and meta-analysis. Molecular Nutrition & Food Research, 59(1), 147-159.
- Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92.
- Khademi, M., Taheri, R. A., &Ghorbani, M. (2024). Novel extraction technologies for enhancement of bioactive compounds from medicinal plants. Food Chemistry, 340, 127950.
- Khalesi, S., Sun, J., Buys, N., &Jamshidi, A. (2014). Green tea catechins and blood pressure: A systematic review and meta-analysis of randomised controlled trials. European Journal of Nutrition, 53(6), 1299-1311.
- Khan, N., Afaq, F., & Mukhtar, H. (2013). Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Letters, 293(2), 133-143.
- Kim, B., Park, J. E., Im, E., Cho, Y., Lee, J., Lee, H. J., Sim, D. Y., Park, W. Y., Shim, B. S., & Kim, S. H. (2021). Recent advances in nanotechnology with nano-phytochemicals: Molecular mechanisms and clinical implications in cancer progression. International Journal of Molecular Sciences, 22(7), 3571.
- Klimczak, M., Beczała, A., & Dzik, R. (2023). Phytochemicals in cancer treatment and cancer prevention—Review on epidemiological data and clinical trials. Nutrients, 15(8), 1896.
- Kumar, S., Pandey, A. K., & Gupta, A. K. (2023). Phytochemical diversity of medicinal and aromatic plants. Scientific Reports, 13, 10987.
- Lekhak, N., & Bhattarai, H. K. (2024). Phytochemicals in cancer chemoprevention: Preclinical and clinical studies. Cancer Control, 31, 10732748241302902.
- Liu, R. H. (2013). Health-promoting components of fruits and vegetables in the diet. Advances in Nutrition, 4(3), 384S-392S.
- Mahato, S. B., & Sen, S. (1997). Advances in triterpenoid research, 1990-1994. Phytochemistry, 44(7), 1185-1236.
- Mahomoodally, M. F. (2013). Traditional medicines in Africa: An appraisal of ten potent African medicinal plants. Evidence-Based Complementary and Alternative Medicine, 2013, 617459.
- Manach, C., Scalbert, A., Morand, C., Rémésy, C., & Jiménez, L. (2004). Polyphenols: Food sources and bioavailability. American Journal of Clinical Nutrition, 79(5), 727-747.
- McClements, D. J., & Xiao, H. (2012). Potential biological fate of ingested nanoemulsions: Influence of particle characteristics. Food & Function, 3(3), 202-220.
- Middleton, E., Kandaswami, C., &Theoharides, T. C. (2000). The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews, 52(4), 673-751.
- Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770-803.
- Newman, D. J., & Cragg, G. M. (2025). The latest advances with natural products in drug discovery and opportunities for the future: A 2025 update. Expert Opinion on Drug Discovery, 20(7), 721-738.
- Panche, A. N., Diwan, A. D., & Chandra, S. R. (2016). Flavonoids: An overview. Journal of Nutritional Science, 5, e47.
- Petrovska, B. B. (2012). Historical review of medicinal plants’ usage. Pharmacognosy Reviews, 6(11), 1-5.
- Posadzki, P., Watson, L., & Ernst, E. (2013). Contamination and adulteration of herbal medicinal products (HMPs): An overview of systematic reviews. European Journal of Clinical Pharmacology, 69(3), 295-307.
- Salehi, B., Quispe, C., Sharifi-Rad, J., Cruz-Martins, N., Nigam, M., Mishra, A. P., Konovalov, D. A., Orobinskaya, V., Abu-Reidah, I. M., Zidorn, C., Mamunur Rashid, M., Maksudur Rahman, M., Sener, B., Kılıç, M., Dursun, B., Sen, S., Acharya, K., Rajkovic, J., &Fokou, P. V. (2024). Caffeic acid: Biological activities and health-promoting effects. Phytotherapy Research, 35(1), 61-80.
- Santini, A., Tenore, G. C., & Novellino, E. (2017). Nutraceuticals: A paradigm of proactive medicine. European Journal of Pharmaceutical Sciences, 96, 53-61.
- Singh, A., Kumar, R., & Sharma, P. (2024). Phytochemicals in drug discovery—A confluence of tradition and innovation. International Journal of Molecular Sciences, 25(16), 8792.
- Singh, A., Sharma, R. K., & Agrawal, B. (2023). Major phytochemicals: Recent advances in health benefits and extraction methods. Molecules, 28(2), 887.
- Tsao, R. (2010). Chemistry and biochemistry of dietary polyphenols. Nutrients, 2(12), 1231-1246.
- Ullah, M. F., Khan, M. W., & Zubair, H. (2016). The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling. Journal of Biological Chemistry, 291(17), 9208-9220.
- Wink, M. (2015). Modes of action of herbal medicines and plant secondary metabolites. Medicines, 2(3), 251-286.
- World Health Organization. (2023). Traditional medicine has a long history of contributing to conventional medicine.